Procedural Results and Long-Term Outcomes of Percutaneous Coronary Intervention for in-Stent Restenosis Chronic Total Occlusion Compared with de novo Chronic Total Occlusion

References

• Ladwiniec A, Allgar V, Thackray S, et al. Medical therapy, percutaneous coronary intervention and prognosis in patients with chronic total occlusions. Heart. 2015;101:1907–1914. doi:10.1136/heartjnl-2015-308181
   PubMed Web of Science ®Google Scholar
• Wilson WM, Walsh SJ, Bagnall A, et al. One-year outcomes after successful chronic total occlusion percutaneous coronary intervention: the impact of dissection re-entry techniques. Catheter Cardiovasc Interv. 2017;90:703–712. doi:10.1002/ccd.26980
   PubMed Web of Science ®Google Scholar
• Valenti R, Migliorini A, De Gregorio MG, et al. Impact of complete percutaneous revascularization in elderly patients with chronic total occlusion. Catheter Cardiovasc Interv. 2020;95:145–153. doi:10.1002/ccd.28452
   PubMed Web of Science ®Google Scholar
• Pinto G, Fragasso G, Gemma M, et al. Long-term clinical effects of recanalization of chronic coronary total occlusions in patients with left ventricular systolic dysfunction. Catheter Cardiovasc Interv. 2020;96:831–838. doi:10.1002/ccd.28850
   PubMed Web of Science ®Google Scholar
• Teramoto T, Tsuchikane E, Yamamoto M, et al. Successful revascularization improves long-term clinical outcome in patients with chronic coronary total occlusion. Int J Cardiol Heart Vasc. 2017;14:28–32.
   PubMed Web of Science ®Google Scholar
• Azzalini L, Vo M, Dens J, Agostoni P. Myths to debunk to improve management, referral, and outcomes in patients with chronic total occlusion of an epicardial coronary artery. Am J Cardiol. 2015;116:1774–1780. doi:10.1016/j.amjcard.2015.08.050
   PubMed Web of Science ®Google Scholar
• Werner GS, Moehlis H, Tischer K. Management of total restenotic occlusions. EuroIntervention. 2009;5(SupplD):D79–D83.
   PubMedGoogle Scholar
• Andreou I, Stone PH. In-stent atherosclerosis at a crossroads: neoatherosclerosis … or paleoatherosclerosis? Circulation. 2016;134:1413–1415. doi:10.1161/CIRCULATIONAHA.116.025129
   PubMed Web of Science ®Google Scholar
• Azzalini L, Dautov R, Ojeda S, et al. Procedural and long-term outcomes of percutaneous coronary intervention for in-stent chronic total occlusion. JACC Cardiovasc Interv. 2017;10:892–902. doi:10.1016/j.jcin.2017.01.047
   PubMed Web of Science ®Google Scholar
• Lee SH, Cho JY, Kim JS, et al. A comparison of procedural success rate and long-term clinical outcomes between in-stent restenosis chronic total occlusion and de novo chronic total occlusion using multicenter registry data. Clin Res Cardiol. 2020;109:628–637. doi:10.1007/s00392-019-01550-7
   PubMed Web of Science ®Google Scholar
• Lamelas P, Padilla L, Abud M, et al. In-stent chronic total occlusion angioplasty in the LATAM-CTO registry. Catheter Cardiovasc Interv. 2021;97:E34–E39. doi:10.1002/ccd.28937
   PubMed Web of Science ®Google Scholar
• Morino Y, Abe M, Morimoto T, et al. Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool. JACC Cardiovasc Interv. 2011;4:213–221. doi:10.1016/j.jcin.2010.09.024
   PubMed Web of Science ®Google Scholar
• Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961–972. doi:10.1056/NEJMoa0804626
   PubMed Web of Science ®Google Scholar
• Christopoulos G, Karmpaliotis D, Alaswad K, et al. The efficacy of “hybrid” percutaneous coronary intervention in chronic total occlusions caused by in-stent restenosis: insights from a US multicenter registry. Catheter Cardiovasc Interv. 2014;84:646–651. doi:10.1002/ccd.25465
   PubMed Web of Science ®Google Scholar
• Hannan EL, Racz M, Holmes DR, et al. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation. 2006;113:2406–2412. doi:10.1161/CIRCULATIONAHA.106.612267
   PubMed Web of Science ®Google Scholar
• de la Torre Hernandez JM, Rumoroso JR, Subinas A, et al. Percutaneous intervention in chronic total coronary occlusions caused by in-stent restenosis: procedural results and long-term clinical outcomes in the TORO (Spanish registry of chronic TOtal occlusion secondary to an occlusive in-stent RestenOsis) multicentre registry. EuroIntervention. 2017;13:e219–e226.
   PubMed Web of Science ®Google Scholar
• Abbas AE, Brewington SD, Dixon SR, et al. Success, safety, and mechanisms of failure of percutaneous coronary intervention for occlusive non-drug-eluting in-stent restenosis versus native artery Total occlusion. Am J Cardiol. 2005;95:1462–1466. doi:10.1016/j.amjcard.2005.01.098
   PubMed Web of Science ®Google Scholar
• Nakazawa G, Otsuka F, Nakano M, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol. 2011;57:1314–1322. doi:10.1016/j.jacc.2011.01.011
   PubMed Web of Science ®Google Scholar
• Cheneau E, Pichard AD, Stabile E, et al. Asymptomatic late stent thrombosis after sirolimus stent implantation. Cardiovasc Radiat Med. 2004;5:57–58.
   PubMedGoogle Scholar
• Abdel-Karim AR, Lombardi WB, Banerjee S, et al. Contemporary outcomes of percutaneous intervention in chronic total coronary occlusions due to in-stent restenosis. Cardiovasc Revasc Med. 2011;12:170–176. doi:10.1016/j.carrev.2010.08.002
   PubMedGoogle Scholar
• Wilson WM, Walsh S, Hanratty C, et al. A novel approach to the management of occlusive in-stent restenosis (ISR). EuroIntervention. 2014;9:1285–1293. doi:10.4244/EIJV9I11A218
   PubMed Web of Science ®Google Scholar
• Karacsonyi J, Tajti P, Rangan BV, et al. Randomized comparison of a CrossBoss first versus standard wire escalation strategy for crossing coronary chronic total occlusions: the CrossBoss First Trial. JACC Cardiovasc Interv. 2018;11:225–233. doi:10.1016/j.jcin.2017.10.023
   PubMed Web of Science ®Google Scholar
• Megaly M, Ali A, Saad M, et al. Outcomes with retrograde versus antegrade chronic total occlusion revascularization. Catheter Cardiovasc Interv. 2020;96:1037–1043. doi:10.1002/ccd.28616
   PubMed Web of Science ®Google Scholar
• Rathore S, Kinoshita Y, Terashima M, et al. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents. EuroIntervention. 2010;5:841–846. doi:10.4244/EIJV5I7A141
   PubMed Web of Science ®Google Scholar
• Magalhaes MA, Minha S, Chen F, et al. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations. Circ Cardiovasc Interv. 2014;7:768–776. doi:10.1161/CIRCINTERVENTIONS.114.001341
   PubMed Web of Science ®Google Scholar
• Singh M, Gersh BJ, McClelland RL, et al. Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis with Tranilast and Its Outcomes (PRESTO) trial. Circulation. 2004;109:2727–2731. doi:10.1161/01.CIR.0000131898.18849.65
   PubMed Web of Science ®Google Scholar
• Hong SJ, Kim BK, Shin DH, et al. Usefulness of intravascular ultrasound guidance in percutaneous coronary intervention with second-generation drug-eluting stents for chronic total occlusions (from the Multicenter Korean-Chronic Total Occlusion Registry). Am J Cardiol. 2014;114:534–540. doi:10.1016/j.amjcard.2014.05.027
   PubMed Web of Science ®Google Scholar
• Goel PK, Khanna R, Pandey CM, et al. Long-term outcomes post chronic total occlusion intervention-implications of completeness of revascularization. J Interv Cardiol. 2018;31:293–301. doi:10.1111/joic.12480
   PubMed Web of Science ®Google Scholar